Reports
Sale
Global Diabetic Ulcer Treatment Market Size, Analysis, Report: By Treatment Type: Wound Care Dressing, Wound care Devices, Active Therapies; By Grade; By Ulcer Types: Neuropathic Ulcers, Ischemic Ulcers, Neuro-Ischemic Ulcers, Others; By End User: Hospital Inpatient Settings, Others; Regional Analysis; Supplier Landscape; 2024-2032
Global Diabetic Ulcer Treatment Market Outlook
The global diabetic ulcer treatment market value was USD 5.11 billion in 2023, driven by the increasing prevalence of diabetes across the globe. The market size is anticipated to grow at a CAGR of 8.1% during the forecast period of 2024-2032 to achieve a value of USD 10.31 billion by 2032.
Rising Cases of Global Diabetes to Bolster the Market Growth of Diabetic Ulcer Treatment
The global market for diabetic ulcer treatment is majorly being driven by the increasing prevalence of diabetes. Diabetes is increasing at a startling rate around the world owing to adoption of sedentary lifestyles and unhealthy eating habits. As a result of this, ulcers caused by diabetes are thus becoming a significant factor contributing to the growth of the market. According to the American Diabetes Association (ADA), patients with diabetes are more prone to gum diseases resulting in a disruption in body’s blood sugar level and giving rise to mouth ulcers.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The development of novel techniques to treat mouth ulcers aided by robust pharmaceutical research and development (R&D) is thereby stimulating the growth of the market. Furthermore, diabetic foot ulcers are becoming a leading cause of concern and, if left untreated, can lead to leg amputation and death in severe cases. These factors are therefore invigorating the growth of the market.
Diabetic Ulcer Treatment: Market Segmentation
Diabetic ulcers are a side effect of chronic diabetes and are usually found in the feet or mouth of the patient. Diabetic patients who depend on insulin are more likely to develop ulcers. The most common types of treatment include wound care dressings and active therapies.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
On the basis of treatment type, the market can be divided into:
- Wound Care Dressing
- Wound Care Devices
- Active Therapies
Wound care dressing can be further divided into antimicrobial dressings, film dressings, and alginate dressings, among others.
Wound care devices can be further segmented into negative pressure wound therapy, hyperbaric oxygen therapy, and ultrasound therapy, among others.
Active therapies can be sub-divided into skin grafts and substitutes, growth factors, and hemostatic agents and sealants, among others.
Based on grade, the market can be categorised into:
- Grade 1
- Grade 2
- Grade 3
- Grade 4
- Grade 5
The market, based on end-suer, can be segmented into:
- Hospital Inpatient Settings
- Hospital Outpatient Settings
- Community Health Centres
- Home Health Care
- Others
The EMR report looks into the regional markets of diabetic ulcer treatment like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Advancements in Medical Technology to Aid the Market Growth of Diabetic Ulcer Treatment
The rise in the global market for diabetic ulcer treatment can be associated with the rising demand for cost-effective treatment options for addressing the concerns of diabetic ulcers. The growing advancements in medical and pharmaceutical technology, such as the introduction of biomaterials for wound healing like skin substitutions, extracellular matrix proteins, and other therapeutic agents, among other treatment options, are providing impetus to the market growth. The robust research programmes implemented in developing wound care products are further expected to promote the adoption of advanced treatment options for bettering the healing process of diabetic ulcers in the coming years. Moreover, the strong market penetration of leading industry players, rising awareness about treatment options, and the flourishing healthcare sector around the world are also expected to have a positive influence on the growth of the market.
Key Industry Players in the Global Diabetic Ulcer Treatment Market
The report presents a detailed analysis of the following key players in the global diabetic ulcer treatment market, looking into their capacity, market share, and latest developments like capacity expansions, plant turnabouts and mergers and acquisitions:
- ConvaTec Group plc
- Acelity L.P. Inc.
- 3M Company
- Smith and Nephew Plc.
- B. Braun Melsungen Ag
- Medline Industries, LP,
- Medtronic Plc
- Organogenesis Holdings Inc
- Molnlycke Health Care AB
- BSN Medical GMBH
- Others
The comprehensive report looks at the micro and macro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of the Porter’s Five Forces Model.
Key Highlights of the Report:
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Treatment Type |
|
| Breakup by Grade |
|
| Breakup by Ulcer Types |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Diabetic Ulcer Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Diabetic Ulcer Epidemiology Analysis
5.1 Epidemiology Overview (2016-2031)
5.2 North America Diabetic Ulcer Treatment Epidemiology (2016-2031)
5.3 Europe Diabetic Ulcer Epidemiology (2016-2031)
5.4 Asia-Pacific Diabetic Ulcer Epidemiology (2016-2031)
5.5 Latin America Diabetic Ulcer Epidemiology (2016-2031)
5.6 Middle East & Africa Diabetic Ulcer Epidemiology (2016-2031)
6 Global Diabetic Ulcer Treatment Market Overview
6.1 Global Diabetic Ulcer Treatment Market Historical Value (2017-2023)
6.2 Global Diabetic Ulcer Treatment Market Forecast Value (2024-2032)
7 Global Diabetic Ulcer Treatment Market Landscape
7.1 Diabetic Ulcer Treatment: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Diabetic Ulcer Treatment: Product Landscape
7.2.1 Analysis by Treatment Type
7.2.2 Analysis by Grade
7.2.3 Analysis by Ulcer Type
7.2.4 Analysis by End User
8 Diabetic Ulcer Treatment Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Global Diabetic Ulcer Treatment Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Global Diabetic Ulcer Treatment Market Segmentation
11.1 Global Diabetic Ulcer Treatment Market by Treatment Type
11.1.1 Market Overview
11.1.2 Wound Care Dressing
11.1.2.1 Antimicrobial Dressings
11.1.2.2 Film Dressings
11.1.2.3 Alginate Dressings
11.1.2.4 Others
11.1.3 Wound care Devices
11.1.3.1 Negative Pressure Wound Therapy
11.1.3.2 Hyperbaric Oxygen Therapy
11.1.3.3 Ultrasound Therapy
11.1.3.4 Others
11.1.4 Active Therapies
11.1.4.1 Skin Grafts and Substitutes
11.1.4.2 Growth Factors
11.1.4.3 Hemostatic Agents and Sealants
11.1.4.4 Other
11.2 Global Diabetic Ulcer Treatment Market by Grade
11.2.1 Market Overview
11.2.2 Grade 1
11.2.3 Grade 2
11.2.4 Grade 3
11.2.5 Grade 4
11.2.6 Grade 5
11.3 Global Diabetic Ulcer Treatment Market by Ulcer Types
11.3.1 Market Overview
11.3.2 Neuropathic Ulcers
11.3.3 Ischemic Ulcers
11.3.4 Neuro-Ischemic Ulcers
11.3.5 Others
11.4 Global Diabetic Ulcer Treatment Market by End User
11.4.1 Market Overview
11.4.2 Hospital Inpatient Settings
11.4.3 Hospital Outpatient Settings
11.4.4 Community Health Centers
11.4.5 Home Healthcare
11.4.6 Others
11.5 Global Diabetic Ulcer Treatment Market by Region
11.5.1 Market Overview
11.5.2 North America
11.5.3 Europe
11.5.4 Asia Pacific
11.5.5 Latin America
11.5.6 Middle East and Africa
12 North America Diabetic Ulcer Treatment Market
12.1 Market Share by Country
12.2 United States of America
12.3 Canada
13 Europe Diabetic Ulcer Treatment Market
13.1 Market Share by Country
13.2 United Kingdom
13.3 Germany
13.4 France
13.5 Italy
13.6 Others
14 Asia Pacific Diabetic Ulcer Treatment Market
14.1 Market Share by Country
14.2 China
14.3 Japan
14.4 India
14.5 ASEAN
14.6 Australia
14.7 Others
15 Latin America Diabetic Ulcer Treatment Market
15.1 Market Share by Country
15.2 Brazil
15.3 Argentina
15.4 Mexico
15.5 Others
16 Middle East and Africa Diabetic Ulcer Treatment Market
16.1 Market Share by Country
16.2 Saudi Arabia
16.3 United Arab Emirates
16.4 Nigeria
16.5 South Africa
16.6 Others
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
17.1.5 Others
18 Patent Analysis
18.1 Analysis by Type of Patent
18.2 Analysis by Publication year
18.3 Analysis by Issuing Authority
18.4 Analysis by Patent Age
18.5 Analysis by CPC Analysis
18.6 Analysis by Patent Valuation
18.7 Analysis by Key Players
19 Grants Analysis
19.1 Analysis by year
19.2 Analysis by Amount Awarded
19.3 Analysis by Issuing Authority
19.4 Analysis by Grant Application
19.5 Analysis by Funding Institute
19.6 Analysis by NIH Departments
19.7 Analysis by Recipient Organization
20 Clinical Trials Analysis
20.1 Analysis by Trial Registration Year
20.2 Analysis by Trial Status
20.3 Analysis by Trial Phase
20.4 Analysis by Therapeutic Area
20.5 Analysis by Geography
21 Funding and Investment Analysis
21.1 Analysis by Funding Instances
21.2 Analysis by Type of Funding
21.3 Analysis by Funding Amount
21.4 Analysis by Leading Players
21.5 Analysis by Leading Investors
21.6 Analysis by Geography
22 Partnership and Collaborations Analysis
22.1 Analysis by Partnership Instances
22.2 Analysis by Type of Partnership
22.3 Analysis by Leading Players
22.4 Analysis by Geography
23 Supplier Landscape
23.1 ConvaTec Group plc
23.1.1 Financial Analysis
23.1.2 Product Portfolio
23.1.3 Demographic Reach and Achievements
23.1.4 Mergers and Acquisitions
23.1.5 Certifications
23.2 Acelity L.P. Inc.
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Mergers and Acquisitions
23.2.5 Certifications
23.3 3M Company
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Mergers and Acquisitions
23.3.5 Certifications
23.4 Smith and Nephew Plc.
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Mergers and Acquisitions
23.4.5 Certifications
23.5 B. Braun Melsungen Ag
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Mergers and Acquisitions
23.5.5 Certifications
23.6 Medline Industries, LP
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Mergers and Acquisitions
23.6.5 Certifications
23.7 Medtronic Plc
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Mergers and Acquisitions
23.7.5 Certifications
23.8 Organogenesis Holdings Inc
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Mergers and Acquisitions
23.8.5 Certifications
23.9 Molnlycke Health Care AB
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Mergers and Acquisitions
23.9.5 Certifications
23.10 BSN Medical GMBH
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Mergers and Acquisitions
23.10.5 Certifications
23.11 Integra LifeSciences Corporation
23.11.1 Financial Analysis
23.11.2 Product Portfolio
23.11.3 Demographic Reach and Achievements
23.11.4 Mergers and Acquisitions
23.11.5 Certifications
23.12 Tissue Regenix
23.12.1 Financial Analysis
23.12.2 Product Portfolio
23.12.3 Demographic Reach and Achievements
23.12.4 Mergers and Acquisitions
23.12.5 Certifications
23.13 Coloplast Corp
23.13.1 Financial Analysis
23.13.2 Product Portfolio
23.13.3 Demographic Reach and Achievements
23.13.4 Mergers and Acquisitions
23.13.5 Certifications
23.14 Cardinal Health.
23.14.1 Financial Analysis
23.14.2 Product Portfolio
23.14.3 Demographic Reach and Achievements
23.14.4 Mergers and Acquisitions
23.14.5 Certifications
23.15 3M
23.15.1 Financial Analysis
23.15.2 Product Portfolio
23.15.3 Demographic Reach and Achievements
23.15.4 Mergers and Acquisitions
23.15.5 Certifications
24 Diabetic Ulcer Treatment - Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
26.1 Very Small Companies
26.2 Small Companies
26.3 Mid-Sized Companies
26.4 Large Companies
26.5 Very Large Companies
27 Payment Methods (Additional Insight)
27.1 Government Funded
27.2 Private Insurance
27.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
In 2023, the global market of diabetic ulcer treatment attained a value of USD 5.11 billion.
The market is anticipated to grow at a CAGR of 8.1% during the forecast period of 2024-2032 to reach a value of USD 10.31 billion by 2032.
The market is being driven by the increasing cases of diabetes due to unhealthy lifestyles resulting in obesity and the corresponding demand for effective treatment against mouth and foot ulcers.
The growth in the market can be associated with the advancements in medical technology leading to the introduction of biomaterials for skin healing.
The major regional markets for diabetic ulcer treatment are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
The different treatment types of diabetic ulcer include wound care dressing, wound care devices, and active therapies.
The significant grades of diabetic ulcer treatment are grade 1, grade 2, grade 3, grade 4, and grade 5.
The major end users of diabetic ulcer treatment are hospital inpatient settings, hospital outpatient settings, community health centres, and home health care, among others.
The major players in the industry are ConvaTec Group plc, Acelity L.P. Inc., 3M Company, Smith and Nephew Plc., B. Braun Melsungen Ag, Medline Industries, LP, Medtronic Plc, Organogenesis Holdings Inc, Molnlycke Health Care AB, and BSN Medical GMBH, among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5999
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 7999
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 9999
$5999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER